Karel Kostev to Patient Selection
This is a "connection" page, showing publications Karel Kostev has written about Patient Selection.
Connection Strength
0.065
-
Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings?. Int J Clin Pharmacol Ther. 2018 Sep; 56(9):411-416.
Score: 0.065